ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
지혈제 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.3%로 54억 3,000만 달러에 달할 전망입니다. 예측 기간 동안 예상되는 성장은 수술 건수 증가, 최소 침습 수술 증가, 성형 수술에 대한 수요 증가, 미용 성형 수술의 급증, 치과 수술에서 효과적인 지혈에 대한 필요성 증가에 기인합니다. 이 기간의 주요 동향으로는 지혈제 배합의 발전, 생물공학제제 및 유전자 재조합제제의 도입, 제품의 보존성 및 안정성 향상, 배합 제품 개발, 합성 지혈제 및 흡수성 지혈제의 기술 혁신 등을 들 수 있습니다.
외과 수술 증가는 지혈제 시장 확대를 견인할 것으로 예측됩니다. 수술은 건강을 위해 신체의 일부를 치료, 복원, 절제하기 위해 의료 전문가가 전문 도구를 사용하여 수행하는 의료 행위입니다. 이러한 수술 증가는 주로 건강 문제를 해결하고 환자의 결과를 개선하기 위해 외과적 개입이 필요한 만성 질환의 발생률 증가에 기인합니다. 지혈제는 출혈을 빠르게 멈추게 하고, 출혈을 최소화하며, 보다 정확한 수술을 위해 수술 부위의 가시성을 높이는 등 수술에서 중요한 역할을 하고 있습니다. 예를 들어, 2023년 3월 영국의 전문 기관인 British Association of Aesthetic Plastic Surgeons(BAAPS)는 2022년에 3 만 1,057 건의 미용 성형 수술이 이루어졌습니다고 보고했으며, 이는 전년 대비 102% 증가한 수치입니다. 이들 시술의 93%를 여성이 차지했으며, 2021년 대비 101% 증가한 것으로 나타났습니다. 이처럼 수술 건수 증가는 지혈제 시장의 성장에 박차를 가하고 있습니다.
지혈제 시장의 주요 시장 진출기업들은 개복 수술과 최소 침습 수술 모두에서 신속하고 효과적인 출혈 제어 및 조직 밀봉을 제공하도록 설계된 콜라겐 기반 지혈제와 같은 혁신적인 제품을 개발하고 있습니다. 콜라겐 지혈제는 정제된 콜라겐 물질로 구성되어 있으며, 상처나 절개 부위에서 신체의 자연 응고를 촉진하여 지혈을 돕습니다. 예를 들어, 2025년 3월 미국 헬스케어 기업 박스터(Baxter)는 흡수성 콜라겐 베이스 패드인 헤모패치(HEMOPATCH) 실링 지혈제를 발표했습니다. 이 첨단 패드는 콜라겐 매트릭스와 NHS-PEG 층을 결합한 듀얼 액션 시스템이 특징이며, 수분에 닿으면 하이드로겔을 형성하여 출혈 부위를 빠르게 봉합할 수 있습니다. 습윤조직에 강력하게 접착하기 때문에 다른 약제로는 부족한 개복수술이나 최소침습수술에도 효과적입니다. 이 패치는 온도 조절 보관이나 특별한 준비가 필요하지 않고 2분 이내에 지혈이 가능하여 수술의 워크플로우를 단순화합니다. 6-8주 이내에 자연적으로 용해되며, 실온에서 최대 3년까지 보관할 수 있어 임상적 및 보존상의 중요한 요구를 충족시킬 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계 성장 분석과 전략 분석 프레임워크
세계의 지혈제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 지혈제 시장 : 성장률 분석
세계의 지혈제 시장 실적 : 규모와 성장, 2019-2024년
세계의 지혈제 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 지혈제 : 전체 시장(TAM)
제6장 시장 세분화
세계의 지혈제 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
트롬빈계 지혈제
젤라틴계 지혈제
콜라겐계 지혈제
산화 재생 셀룰로오스계 지혈제
복합 지혈 겸자
피브린 실란트
기타
세계의 지혈제 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
트라우마
심혈관외과
일반외과
성형외과
정형외과
뇌신경외과
기타
세계의 지혈제 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
수술센터
요양시설
기타
세계의 지혈제 시장 : 트롬빈계 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
소 유래 트롬빈
인간 유래 트롬빈
산화 재생 셀룰로오스(Orc) Ine Thrombin
복합 트롬빈 제품
세계의 지혈제 시장 : 젤라틴계 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
흡수성 젤라틴 스펀지
젤라틴 파우더
젤라틴 페이스트
트롬빈 젤라틴
세계의 지혈제 시장 : 콜라겐계 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
콜라겐 스펀지
콜라겐 파우더
트롬빈 콜라겐
콜라겐 시트 또는 패치
세계의 지혈제 시장 : 산화 재생 셀룰로오스계 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
산화 재생 셀룰로오스(ORC) 패드
산화 재생 셀룰로오스(ORC) 메시
산화 재생 셀룰로오스(ORC) 분말
산화 재생 셀룰로오스(ORC)와 기타 활성제
세계의 지혈제 시장 : 복합 지혈 겸자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
젤라틴과 트롬빈 조합
콜라겐과 트롬빈 조합
산화 재생 셀룰로오스(ORC)와 트롬빈 조합
멀티 에이전트 조합
세계의 지혈제 시장 : 피브린 실란트별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
인간 혈장 유래 피브린 실란트
재조합 피브린 실란트
스프레이 피브린 실란트
액체 피브린 실란트
항균제 배합 피브린 실란트
세계의 지혈제 시장 : 기타별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
다당류 기반 지혈제
합성 고분자 기반 지혈제
미세섬유 콜라겐 지혈제
키토산 기반 지혈제
칼슘 기반 지혈제
제7장 지역별/국가별 분석
세계의 지혈제 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 지혈제 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
지혈제 시장 : 경쟁 구도
지혈제 시장 : 기업 개요
Pfizer Inc.
Johnson & Johnson Services Inc.
Becton, Dickinson & Co.
CSL Ltd.
Baxter International Inc.
제31장 기타 주요 기업 및 혁신 기업
Teleflex Inc.
Integra LifeSciences Holdings Corp.
Gelita Medical
Artivion Inc.
B. Braun Melsungen AG
Advanced Medical Solutions Group Plc
Z-Medica
Marine Polymer Technologies Inc.
MedTrade Products Ltd.
Samyang Holdings Corp.
Vascular Solutions Pc
BioCer Entwicklungs GmbH
Starch Medical Inc.
Arch Therapeutics Inc.
Medcura Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 전략
지혈제 시장, 2029년 : 새로운 기회를 제공하는 국가
지혈제 시장, 2029년 : 새로운 기회를 제공하는 부문
지혈제 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Hemostatic agents are specialized substances designed to assist the body's natural blood clotting process by controlling and stopping bleeding. They work by interacting with different components of the coagulation system to promote the formation of a stable clot at the site of vascular injury.
The primary types of hemostatic agents include thrombin-based, gelatin-based, collagen-based, oxidized regenerated cellulose-based, combination hemostats, fibrin sealants, and others. Thrombin-based hemostats use thrombin, a natural blood enzyme, to quickly halt bleeding by accelerating clot formation. These agents are used in trauma care, cardiovascular surgery, general surgery, plastic surgery, orthopedic surgery, neurosurgery, and more, serving end users such as hospitals, surgical centers, nursing homes, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The hemostatic agents market research report is one of a series of new reports from The Business Research Company that provides hemostatic agents market statistics, including hemostatic agents industry global market size, regional shares, competitors with a hemostatic agents market share, detailed hemostatic agents market segments, market trends and opportunities, and any further data you may need to thrive in the hemostatic agents industry. This hemostatic agents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemostatic agents market size has grown strongly in recent years. It will grow from $4.19 billion in 2024 to $4.42 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to the aging global population, increasing trauma and accident cases, higher prevalence of cardiovascular disorders, rising incidence of bleeding disorders like hemophilia, and a growing number of patients suffering from liver diseases and coagulation abnormalities.
The hemostatic agents market size is expected to see strong growth in the next few years. It will grow to $5.43 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth expected in the forecast period can be attributed to the rising number of surgical procedures, growth in minimally invasive surgeries, increased demand for orthopedic surgeries, a surge in cosmetic and aesthetic surgeries, and a growing need for effective hemostasis in dental surgeries. Key trends during this period include advancements in hemostatic agent formulations, the introduction of bioengineered and recombinant agents, improved product shelf-life and stability, development of combination products, and innovation in synthetic and absorbable hemostats.
The growing number of surgical procedures is anticipated to drive the expansion of the hemostatic agents market moving forward. Surgical procedures involve medical operations carried out by healthcare professionals using specialized tools to treat, repair, or remove parts of the body for health purposes. This increase in surgeries is mainly due to the rising incidence of chronic conditions that often require surgical intervention to address health problems and improve patient outcomes. Hemostatic agents play a crucial role in surgeries by quickly stopping bleeding, minimizing blood loss, and enhancing visibility in the surgical field for more precise work. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons (BAAPS), a UK professional body, reported 31,057 cosmetic procedures performed in 2022, marking a 102% increase from the previous year. Women accounted for 93% of these procedures, showing a 101% rise compared to 2021. Thus, the growing number of surgical procedures is fueling the growth of the hemostatic agents market.
Key players in the hemostatic agents market are developing innovative products, such as collagen-based hemostats, designed to provide rapid and effective bleeding control and tissue sealing in both open and minimally invasive surgeries. Collagen-based hemostats consist of purified collagen materials that aid hemostasis by enhancing the body's natural clotting at wound or incision sites. For instance, in March 2025, Baxter, a US healthcare company, introduced HEMOPATCH Sealing Hemostat, an absorbable collagen-based pad. This advanced pad features a dual-action system that combines a collagen matrix with an NHS-PEG layer, which forms a hydrogel when it contacts moisture, enabling fast sealing of bleeding areas. It adheres strongly to wet tissues, making it effective in both open and minimally invasive surgical procedures where other agents may fall short. The patch achieves hemostasis in less than two minutes without requiring temperature-controlled storage or special preparation, simplifying surgical workflows. It naturally dissolves within 6 to 8 weeks and can be stored at room temperature for up to three years, meeting critical clinical and storage needs.
In May 2025, Merit Medical Systems Inc., a US medical device manufacturer, acquired Biolife Delaware LLC for an undisclosed sum. This acquisition positions Merit to offer a wider range of products that enhance consistency and efficiency in post-procedure care. It also strengthens Merit's portfolio with specialized hemostatic solutions suitable for various clinical applications, including bleeding management from vascular closures and indwelling catheters. Biolife Delaware LLC is a US-based producer of hemostatic agents.
Major players in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., and Biom'Up SAS.
North America was the largest region in the hemostatic agents market in 2024. The regions covered in hemostatic agents report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the hemostatic agents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The hemostatic agents market consists of sales of chitosan-based hemostats, flowable hemostats, synthetic polymer-based hemostats, topical absorbable hemostats, and adhesive hemostatic films. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hemostatic Agents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hemostatic agents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hemostatic agents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostatic agents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Thrombin-Based Hemostats; Gelatin-Based Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Combination Hemostats; Fibrin Sealants; Other Types
2) By Application: Trauma; Cardiovascular Surgery; General Surgery; Plastic Surgery; Orthopedic Surgery; Neurosurgery; Other Applications
3) By End-User: Hospitals; Surgery Centers; Nursing Homes; Other End Users
Subsegments:
1) By Thrombin-Based Hemostats: Bovine Thrombin; Human Thrombin; Poxidized Regenerated Cellulose (Orc)Ine Thrombin; Combined Thrombin Products
2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges; Gelatin Powder; Gelatin Paste; Gelatin With Thrombin
3) By Collagen-Based Hemostats: Collagen Sponges; Collagen Powder; Collagen With Thrombin; Collagen Sheets Or Patches
4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads; Oxidized Regenerated Cellulose (ORC) Mesh; Oxidized Regenerated Cellulose (ORC) Powder; Oxidized Regenerated Cellulose (ORC) With Other Active Agents
5) By Combination Hemostats: Gelatin And Thrombin Combinations; Collagen And Thrombin Combinations; Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations; Multi-Agent Combinations
6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants; Recombinant Fibrin Sealants; Sprayable Fibrin Sealants; Liquid Fibrin Sealants; Fibrin Sealants With Antimicrobials
7) By Other Types: Polysaccharide-Based Hemostats; Synthetic Polymer-Based Hemostats; Microfibrillar Collagen Hemostats; Chitosan-Based Hemostats; Calcium-Based Hemostats
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Becton, Dickinson & Co.; CSL Ltd.; Baxter International Inc.; Teleflex Inc.; Integra LifeSciences Holdings Corp.; Gelita Medical; Artivion Inc.; B. Braun Melsungen AG; Advanced Medical Solutions Group Plc; Z-Medica; Marine Polymer Technologies Inc.; MedTrade Products Ltd.; Samyang Holdings Corp.; Vascular Solutions Pc; BioCer Entwicklungs GmbH; Starch Medical Inc.; Arch Therapeutics Inc.; Medcura Inc.; Biom'Up SAS.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Hemostatic Agents Market Characteristics
3. Hemostatic Agents Market Trends And Strategies
4. Hemostatic Agents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Hemostatic Agents Growth Analysis And Strategic Analysis Framework
5.1. Global Hemostatic Agents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hemostatic Agents Market Growth Rate Analysis
5.4. Global Hemostatic Agents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hemostatic Agents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hemostatic Agents Total Addressable Market (TAM)
6. Hemostatic Agents Market Segmentation
6.1. Global Hemostatic Agents Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thrombin-Based Hemostats
Gelatin-Based Hemostats
Collagen-Based Hemostats
Oxidized Regenerated Cellulose-Based Hemostats
Combination Hemostats
Fibrin Sealants
Other Types
6.2. Global Hemostatic Agents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trauma
Cardiovascular Surgery
General Surgery
Plastic Surgery
Orthopedic Surgery
Neurosurgery
Other Applications
6.3. Global Hemostatic Agents Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Surgery Centers
Nursing Homes
Other End Users
6.4. Global Hemostatic Agents Market, Sub-Segmentation Of Thrombin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bovine Thrombin
Human Thrombin
Poxidized Regenerated Cellulose (Orc)Ine Thrombin
Combined Thrombin Products
6.5. Global Hemostatic Agents Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Absorbable Gelatin Sponges
Gelatin Powder
Gelatin Paste
Gelatin With Thrombin
6.6. Global Hemostatic Agents Market, Sub-Segmentation Of Collagen-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Collagen Sponges
Collagen Powder
Collagen With Thrombin
Collagen Sheets Or Patches
6.7. Global Hemostatic Agents Market, Sub-Segmentation Of Oxidized Regenerated Cellulose-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oxidized Regenerated Cellulose (ORC) Pads
Oxidized Regenerated Cellulose (ORC) Mesh
Oxidized Regenerated Cellulose (ORC) Powder
Oxidized Regenerated Cellulose (ORC) With Other Active Agents
6.8. Global Hemostatic Agents Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gelatin And Thrombin Combinations
Collagen And Thrombin Combinations
Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations
Multi-Agent Combinations
6.9. Global Hemostatic Agents Market, Sub-Segmentation Of Fibrin Sealants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Plasma-Derived Fibrin Sealants
Recombinant Fibrin Sealants
Sprayable Fibrin Sealants
Liquid Fibrin Sealants
Fibrin Sealants With Antimicrobials
6.10. Global Hemostatic Agents Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polysaccharide-Based Hemostats
Synthetic Polymer-Based Hemostats
Microfibrillar Collagen Hemostats
Chitosan-Based Hemostats
Calcium-Based Hemostats
7. Hemostatic Agents Market Regional And Country Analysis
7.1. Global Hemostatic Agents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hemostatic Agents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
